Boston Scientific Corp (BSX)
Net profit margin
| Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
|---|---|---|---|---|---|---|
| Net income | US$ in thousands | 1,591,000 | 698,000 | 1,041,000 | -82,000 | 4,700,000 |
| Revenue | US$ in thousands | 13,975,000 | 12,190,000 | 11,625,000 | 9,552,000 | 10,348,000 |
| Net profit margin | 11.38% | 5.73% | 8.95% | -0.86% | 45.42% |
December 31, 2023 calculation
Net profit margin = Net income ÷ Revenue
= $1,591,000K ÷ $13,975,000K
= 11.38%
The net profit margin of Boston Scientific Corp. has varied over the past five years. In 2019, the company achieved a high net profit margin of 43.76%, indicating efficient cost management and strong revenue generation relative to expenses. However, in 2020, the net profit margin declined significantly to -1.15%, suggesting the company faced challenges that impacted profitability.
Subsequently, in 2021, the net profit margin improved to 8.28%, signaling a recovery in profitability. This positive trend continued in 2022 with a further increase to 5.05%. The most recent data for 2023 shows a notable improvement in the net profit margin to 11.03%, indicating the company's enhanced ability to convert revenue into profit.
Overall, the fluctuation in Boston Scientific Corp.'s net profit margin reflects changes in the company's financial performance and efficiency in managing costs and revenues over the analyzed period. The upward trend in recent years suggests increasing profitability and potential financial stability.
Peer comparison
Dec 31, 2023